Key result
Resveratrol treatment reduced urotensin 2 and its receptors in the heart tissues of diabetic rats compared to the control group.
Why the study?
Diabetes carries a serious risk of cardiovascular complications, and urotensin 2 and its receptors contribute to cardiovascular diseases via reactive oxygen species.
Does resveratrol affect the level of urotensin 2 and its receptors in the heart tissues of diabetic rats?
Does resveratrol affect the level of urotensin 2 and its receptors in the heart tissues of diabetic rats?
Answers are grounded in this paper and cite their sources.
May support further investigation of resveratrol in diabetic cardiomyopathy; leaves open clinical translation pending human data.
Background: Individuals with diabetes mellitus are at serious risk of a wide range of cardiovascular complications. Urotensin 2 and its receptors play an important role in the development of cardiovascular diseeases through production of reactive oxygen species (ROS). Resveratrol is a polyphenol with antioxidant and anti-diabetic properties. The present study aimed to investigate the effects of resveratrol on urotensin 2 and its receptors in the heart tissues of diabetic rats.
No takes yet. Share an insight, caveat, or question.
Rahimikian et al. (2020) studied Type 2 diabetes (n=48). Resveratrol vs. Diabetic control group was evaluated on Urotensin 2 and its receptor levels in heart tissue (p=<0.001). Resveratrol treatment reduced urotensin 2 and its receptors in the heart tissues of diabetic rats compared to the control group.
Synapse has enriched 10 related papers. Consider them for comparative context: